IKS Health Delivers Strong Q4 FY25 Performance with 17% YoY Revenue and 133% YoY PAT Growth

Inventurus Knowledge Solutions Limited, known as IKS Health, a technology-enabled healthcare solutions provider, has reported its financial results for the quarter ended March 31, 2025. The company highlighted strong growth in Q4 FY25 with a 17% YoY revenue growth in INR and 13% YoY in USD, and a 133% YoY PAT growth. The Q4 EBITDA was up 68% YoY and 13% QoQ, while the Adjusted PAT was up 108% YoY and 14% QoQ. The company's Q4 deal wins demonstrated strong momentum toward full platform engagements, reflecting growing client confidence in IKS Health’s ability to deliver on the vision of an integrated care enablement platform.